Comparison between Aye Finance IPO and Gaudium IVF IPO.
Aye Finance IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Gaudium IVF IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Aye Finance IPO is up to ₹1,010.00 Cr whereas the issue size of the Gaudium IVF IPO is up to ₹165.00 Cr. The final issue price of Aye Finance IPO is ₹129.00 per share and of Gaudium IVF IPO is ₹79.00 per share.
| Aye Finance IPO | Gaudium IVF IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹5 per share |
| Issue Price (Lower) | ₹122.00 per share | ₹75.00 per share |
| Issue Price (Upper) | ₹129.00 per share | ₹79.00 per share |
| Issue Price (Final) | ₹129.00 per share | ₹79.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 116 shares | 189 shares |
| Fresh Issue Size | 5,50,38,759 shares | 1,13,92,500 shares |
| Fresh Issue Size (Amount) | up to ₹710.00 Cr | up to ₹90.00 Cr |
| OFS Issue Size | 2,32,55,812 shares | 94,93,700 shares |
| OFS Issue Size (Amount) | up to ₹300.00 Cr | up to ₹75.00 Cr |
| Issue Size Total | 7,82,94,571 shares | 2,08,86,200 shares |
| Issue Size Total (Amount) | up to ₹1,010.00 Cr | up to ₹165.00 Cr |
Aye Finance IPO opens on Feb 09, 2026, while Gaudium IVF IPO opens on Feb 20, 2026. The closing date of Aye Finance IPO and Gaudium IVF IPO is Feb 11, 2026, and Feb 24, 2026, respectively.
| Aye Finance IPO | Gaudium IVF IPO | |
|---|---|---|
| Anchor Bid Date | Feb 06, 2026 | Feb 19, 2026 |
| Issue Open | Feb 09, 2026 | Feb 20, 2026 |
| Issue Close | Feb 11, 2026 | Feb 24, 2026 |
| Basis Of Allotment (Tentative) | Feb 12, 2026 | Feb 25, 2026 |
| Initiation of Refunds (Tentative) | Feb 13, 2026 | Feb 25, 2026 |
| Credit of Share (Tentative) | Feb 13, 2026 | Feb 26, 2026 |
| Listing date (Tentative) | Feb 16, 2026 | Feb 27, 2026 |
| Anchor Lockin End date 1 | Mar 13, 2026 | Mar 26, 2026 |
| Anchor Lockin End date 2 | May 12, 2026 | May 25, 2026 |
Aye Finance IPO P/E ratio is 14.11, as compared to Gaudium IVF IPO P/E ratio of 25.36.
| Aye Finance IPO | Gaudium IVF IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 71.30 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 14.11 | 25.36 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹3183.52 Cr. | ₹575.02 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 12.12% | 41.31% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 39.70% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.73 | 0.41 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹9.14 | ₹3.12 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 12.12% | 41.71% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Aye Finance IPO Retail Individual Investors (RII) are offered 78,29,456 shares while in Gaudium IVF IPO retail investors are offered 78,29,456 shares. Qualified Institutional Buyers (QIB) are offered 2,34,88,372 shares in Aye Finance IPO and 41,77,240 shares in Gaudium IVF IPO.
| Aye Finance IPO | Gaudium IVF IPO | |
|---|---|---|
| Anchor Investor Reservation | 3,52,32,558 shares | 62,65,860 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 2,34,88,372 shares | 41,77,240 shares |
| NII | 1,17,44,185 shares | 31,32,930 shares |
| RII | 78,29,456 shares | 73,10,170 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 7,82,94,571 shares | 2,08,86,200 shares |
Aye Finance IPO subscribed 1.04x in total, whereas Gaudium IVF IPO subscribed 7.27x.
| Aye Finance IPO | Gaudium IVF IPO | |
|---|---|---|
| QIB (times) | 1.62x | 1.62x |
| NII (times) | 0.05x | 14.05x |
| Big NII (times) | 0.02x | 12.71x |
| Small NII (times) | 0.11x | 16.73x |
| RII (times) | 0.81x | 7.60x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.04x | 7.27x |
